The patient journey and burden of disease in progressive pulmonary fibrosis in Japan: a cross-sectional survey by Yuko Kaneko, Yuko Waseda, Hidekata Yasuoka, Masateru Okazaki, Shoko Nagata, Ryoko Iwasaki, Mark Small, Haruyuki Ishii

Get full text

Predictive value of 3′-deoxy-3′-18F-fluorothymidine PET in the early response to anti-programmed death-1 therapy in patients with advanced non-small cell lung cancer by Yukihiro Umeda, Miwa Morikawa, Masaki Anzai, Maiko Kadowaki, Yuko Waseda, Tetsuya Tsujikawa, Yasushi Kiyono, Hidehiko Okazawa, Tamotsu Ishizuka, Masayuki Sato, Tetsuya Mori

Get full text

Predictive value of integrated 18F-FDG PET/MRI in the early response to nivolumab in patients with previously treated non-small cell lung cancer by Yukihiro Umeda, Miwa Morikawa, Masaki Anzai, Shingo Ameshima, Maiko Kadowaki, Yuko Waseda, Hiroko Shigemi, Tetsuya Tsujikawa, Yasushi Kiyono, Hidehiko Okazawa, Tamotsu Ishizuka

Get full text

3′-deoxy-3′-18F-fluorothymidine PET imaging of lymphoid tissues in patients with advanced non-small cell lung cancer undergoing anti-programmed cell death-1 therapy by Masayuki Sato, Yukihiro Umeda, Tetsuya Tsujikawa, Tetsuya Mori, Akikazu Shimada, Tomoaki Sonoda, Makiko Yamaguchi, Chisato Honjo, Yuko Waseda, Yasushi Kiyono, Tamotsu Ishizuka, Hidehiko Okazawa

Get full text